Alkem to hold Q4FY26 results conference call on May 28

Alkem Laboratories Ltd. will hold a conference call for investors and analysts on Thursday, May 28, 2026, from 4:30 pm to 5:30 pm IST to discuss its Q4 and FY26 financial results. The call will follow the announcement of the Company’s Q4 and FY26 financial results on Thursday, May 28, 2026.

Conference Call Details

The discussion will focus on the Q4 and FY26 financial results. Alkem Laboratories Ltd. will be represented on the call by Mr. Sandeep Singh - MD, Dr. Vikas Gupta – CEO, and Mr. Nitin Agrawal – CFO. Motilal Oswal Securities Ltd. will host the call.

Dial-in Information

Participants can join the call using the domestic and international dial-in numbers provided below. Investors are requested to dial in 10 minutes ahead of the scheduled start time.

Region	Dial-in Numbers
India	+91 22 6280 1149 / +91 22 7115 8050
USA	1 866 746 2133
UK	0 808 101 1573
Singapore	800 101 2045
Hong Kong	800 964 448

An express join option is available via the Diamond Pass link provided by the company. The company has communicated this notice to the stock exchanges to ensure compliance with regulatory disclosure requirements.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.76%	-3.08%	-5.13%	-5.18%	+0.57%	+79.94%

Alkem Laboratories has announced the appointment of Mr. Chanakya Misra to a senior management position within the company, effective 18 May 2026. The disclosure was made pursuant to Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and was communicated to both BSE Limited and the National Stock Exchange of India Limited.

Appointment Details

The following table summarises the key details of the appointment as disclosed by the company:

Parameter:	Details
Name:	Mr. Chanakya Misra
Reason for Change:	Appointment
Date of Appointment:	18 May 2026
Term of Appointment:	Duration of the contract shall be so long as he is in employment of the Company
Relationship with Directors:	Not Applicable

Professional Profile

Mr. Chanakya Misra holds an MBA in Marketing & International Business and a Bachelor of Pharmacy from IIT (BHU). He brings with him over 25 years of professional experience spanning pharmaceuticals, public health, rare diseases, and healthcare ecosystems.

Regulatory Compliance

The disclosure was made in accordance with Regulation 30 read with Schedule III, Part A of the SEBI LODR Regulations, as well as the SEBI Master Circular bearing reference HO/49/14/14(7)2025-CFDDPOD2/1/3762/2026 dated January 30, 2026. The filing was signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer of Alkem Laboratories. The information has also been made available on the company's official website.